{"id":360118,"date":"2021-04-07T11:16:24","date_gmt":"2021-04-07T15:16:24","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=360118"},"modified":"2021-04-07T11:16:24","modified_gmt":"2021-04-07T15:16:24","slug":"el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/","title":{"rendered":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \u00abSus beneficios superan los riesgos\u00bb"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>\u00c1msterdam.-<\/strong><\/em>El comit\u00e9 de seguridad de la Agencia Europea de Medicamentos indic\u00f3 que el balance de riesgos y beneficios del f\u00e1rmaco sigue siendo positivo.<!--more--><\/p>\n<p style=\"text-align: justify;\">El ente regulador europeo reiter\u00f3 este mi\u00e9rcoles que \u00ablos beneficios generales del uso de la vacuna de AstraZeneca contra el coronavirus superan los riesgos\u00bb, al concluir que efectos adversos como la formaci\u00f3n de co\u00e1gulos son \u00abmuy raros\u00bb.<\/p>\n<p style=\"text-align: justify;\">El comit\u00e9 de seguridad de la Agencia Europea de Medicamentos (EMA), que tiene su sede en \u00c1msterdam, Pa\u00edses Bajos, indic\u00f3 que el balance de riesgos y beneficios del f\u00e1rmaco sigue siendo \u00abpositivo\u00bb y respald\u00f3 que ese inoculante, junto a los otros que autoriz\u00f3, son \u00abseguros y eficaces\u00bb.T\u00e9lam.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1msterdam.-El comit\u00e9 de seguridad de la Agencia Europea de Medicamentos indic\u00f3 que el balance de riesgos y beneficios del f\u00e1rmaco sigue siendo positivo.<\/p>\n","protected":false},"author":11,"featured_media":360123,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[6225,5161,487,882,6226],"class_list":["post-360118","post","type-post","status-publish","format-standard","has-post-thumbnail","category-internacionales","tag-agencia","tag-astrazeneca","tag-europa","tag-medicamentos","tag-respaldo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: &quot;Sus beneficios superan los riesgos&quot; - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: &quot;Sus beneficios superan los riesgos&quot; - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"\u00c1msterdam.-El comit\u00e9 de seguridad de la Agencia Europea de Medicamentos indic\u00f3 que el balance de riesgos y beneficios del f\u00e1rmaco sigue siendo positivo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T15:16:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"680\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"vrios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"vrios\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/\"},\"author\":{\"name\":\"vrios\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\"},\"headline\":\"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \u00abSus beneficios superan los riesgos\u00bb\",\"datePublished\":\"2021-04-07T15:16:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/\"},\"wordCount\":131,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Vacuna.jpg\",\"keywords\":[\"Agencia\",\"AstraZeneca\",\"Europa\",\"Medicamentos\",\"Respaldo\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/\",\"name\":\"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \\\"Sus beneficios superan los riesgos\\\" - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Vacuna.jpg\",\"datePublished\":\"2021-04-07T15:16:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Vacuna.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Vacuna.jpg\",\"width\":1024,\"height\":680,\"caption\":\"El litoral\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/04\\\/07\\\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \u00abSus beneficios superan los riesgos\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"width\":140,\"height\":44,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\",\"name\":\"vrios\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/vrios\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \"Sus beneficios superan los riesgos\" - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/","og_locale":"es_ES","og_type":"article","og_title":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \"Sus beneficios superan los riesgos\" - .::Agencia IP::.","og_description":"\u00c1msterdam.-El comit\u00e9 de seguridad de la Agencia Europea de Medicamentos indic\u00f3 que el balance de riesgos y beneficios del f\u00e1rmaco sigue siendo positivo.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-04-07T15:16:24+00:00","og_image":[{"width":1024,"height":680,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg","type":"image\/jpeg"}],"author":"vrios","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"vrios","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/"},"author":{"name":"vrios","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039"},"headline":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \u00abSus beneficios superan los riesgos\u00bb","datePublished":"2021-04-07T15:16:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/"},"wordCount":131,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg","keywords":["Agencia","AstraZeneca","Europa","Medicamentos","Respaldo"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/","name":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \"Sus beneficios superan los riesgos\" - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg","datePublished":"2021-04-07T15:16:24+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/04\/Vacuna.jpg","width":1024,"height":680,"caption":"El litoral"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/04\/07\/el-ente-regulador-europeo-respaldo-la-vacuna-de-astrazeneca-sus-beneficios-superan-los-riesgos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"El ente regulador europeo respald\u00f3 la vacuna de AstraZeneca: \u00abSus beneficios superan los riesgos\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","width":140,"height":44,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039","name":"vrios","url":"https:\/\/www.ip.gov.py\/ip\/author\/vrios\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/360118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=360118"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/360118\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/360123"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=360118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=360118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=360118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}